CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 95 filers reported holding CARIBOU BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $988,000 | – | 41,393 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 674,196 | $6,189,000 | 7.17% |
| 72 Investment Holdings, LLC | 474,067 | $4,352,000 | 4.76% |
| Velan Capital Investment Management LP | 210,695 | $1,934,000 | 1.80% |
| PFM Health Sciences, LP | 4,370,545 | $40,122,000 | 1.50% |
| Monashee Investment Management LLC | 470,000 | $4,315,000 | 1.25% |
| Avidity Partners Management LP | 2,819,067 | $25,879,000 | 0.54% |
| Rokos Capital Management LLP | 849,334 | $7,899,000 | 0.37% |
| Green Alpha Advisors, LLC | 49,674 | $456,000 | 0.31% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 181,304 | $1,664,000 | 0.25% |
| Tekla Capital Management LLC | 699,377 | $6,420,000 | 0.22% |